ArticleHuman vaccines & immunotherapeutics2016

Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment.

Siobhán McCleanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.